Other
Gingival Recession
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Gingival Recession is an early-stage landscape with 0 programs across 1 company. The most active players are Zeliha Başak Çakır Erdil.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed10 · 53%
Unknown status5 · 26%
Recruiting2 · 11%
Withdrawn1 · 5%
Not yet recruiting1 · 5%
Clinical Trials
Trial Activity
19 trials
VCMX, PRF and SCTG Treatment in the Gingival Recessions
Completed·—·Phase 3·NCT07345520·60 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)